Allena Pharmaceuticals Inc (ALNA)


Stock Price Forecast

Sept. 28, 2022


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Allena Pharmaceuticals Inc chart...

About the Company

We do not have any company description for Allena Pharmaceuticals Inc at the moment.

Please visit http://www.allenapharma.com/ for more information about the company.

CEO

Louis Brenner

Exchange

NASDAQ

Website

http://www.allenapharma.com/

$M

Total Revenue

41

Employees

$2M

Market Capitalization

-0.20

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ALNA News

Allena Pharmaceuticals (NASDAQ: ALNA)

1y ago, source: The Motley Fool

Allena Pharmaceuticals, Inc. engages in the development, discovery, and commercialization of oral enzyme therapeutics to treat patients with kidney disorders. Its product pipeline includes ...

Allena Pharmaceuticals Inc. (ALNAQ)

1y ago, source: Nasdaq

*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past ...

Allena Pharmaceuticals (ALNA) Enters Overbought Territory

1y ago, source: AOL

Allena Pharmaceuticals, Inc. ALNA has moved higher as of late, but there could definitely be trouble on the horizon for this company. That is because ALNA is now in overbought territory with an ...

Allena Pharma (ALNAQ) Earnings Dates & Reports

14d ago, source: Investing

View upcoming earnings forecasts and in-depth analysis of company forecasts.

CNFinance Hldgs Stock (NYSE:CNF), Quotes and News Summary

1mon ago, source: Benzinga.com

This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after ...

Alnylam Pharmaceuticals

5d ago, source: Forbes

Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new ...

Frazier Healthcare VI, L.P.'s Net Worth

1mon ago, source: Benzinga.com

Who is Frazier Healthcare VI, L.P.? Frazier Healthcare VI, L.P. has an estimated net worth of $132 Million. This is based on reported shares across multiple companies, which include COLLEGIUM ...

Amylyx Pharmaceuticals Inc AMLX

3d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Vertex Pharmaceuticals Inc VRTX

3d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

SNOA Sonoma Pharmaceuticals, Inc.

3d ago, source: Seeking Alpha

Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the ...

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue Estimates

20d ago, source: Yahoo Finance

Mirum Pharmaceuticals, Inc. (MIRM) came out with a quarterly loss of $0.66 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to loss of $0.99 per share a year ago.

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...